Compass Pathways

2 trends tracked about this subject — the full history, oldest to newest below.

◼ Archived Business

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Usona has filed a New Drug Application for its psilocybin depression treatment, intensifying the competitive race with Compass Pathways for FDA approval.

5 sources 5 articles v 3 11d ago

◼ Archived Business 🔮 fades

Compass says depression drug has long-lasting benefits

Compass Pathways' psilocybin depression therapy shows six‑month durability, sparking market optimism.

5 sources 5 articles v 3 130d ago